Editor's Note
The Food and Drug Administration on June 27 announced the recall by PharMEDium Services of specific lots of potassium phosphate and succinylcholine chloride because of a lack of sterility assurance.
The products being recalled were compounded using certain Hospira products, which were recalled on June 15 because microbial growth was found during a routine simulation of the manufacturing process.
Posted 06/27/2017] AUDIENCE: Pharmacy ISSUE: PharMEDium Services is conducting a limited, voluntary recall due to Hospira Inc.'s ("Hospira") June 15, 2017 recall announcement that microbial growth was detected during a routine simulation of the manufacturing process and therefore there was a lack of sterility assurance.
Read More >>The promise of quicker recovery and fewer complications from sedation,…
New York, New York (January 31, 2024)–Sonio today announced that…
The US Food and Drug Administration receives more than 100,000…